While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

Testing that can help with the early detection and treatment of diseases including cancer, Alzheimer’s and multiple sclerosis will be accessible to more patients soon. Right now, health insurance ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Multiple myeloma usually does not show any symptoms in the early stages. The only diagnosis comes from routine testing of blood or urine. There is no exact cause of multiple myeloma. Symptoms are ...

The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

CARTITUDE-4 compared Carvykti to a pair of three-drug multiple myeloma regimens – pomalidomide ... Meanwhile, both J&J and BMS are testing their CAR-Ts as first-line therapy – respectively ...

Campbell, Dennis, Srikant M. Datar, Susan L. Kulp, and V.G. Narayanan. "Testing Strategy with Multiple Performance Measures: Evidence from a Balanced Scorecard at ...

While prior research showed that multiple myeloma patients safely tolerated ... Circulating tumor DNA testing shows limited benefits for certain colorectal cancer patients For patients who have ...